Selective methylene oxidation in α,β-unsaturated carbonyl natural products.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41115455.
- Also identified by DOI 10.1038/s41586-025-09742-0 and PMC identifier 12616576.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
α,β-Unsaturated carbonyl groups-which feature conjugated C=C and C=O bonds-are common in bioactive compounds. Late-stage functionalization of these compounds could involve oxidation of methylene (2°) C-H bonds while leaving the C=C double bonds that are important for biological activity intact<sup>1-3</sup>. Although catalytic systems have been developed for selective oxidation of methylenes in the presence of aromatics<sup>4</sup> and N-heterocycles<sup>5</sup>, olefins remain a long-standing challenge. Here we show that replacing the carboxylic acid with a hydrogen bond donor solvent in sterically hindered manganese PDP ([N,N'-bis(2-pyridylmethyl)]-2,2'-bipyrrolidine) catalysts changes the active oxidant to one that accelerates electron-rich methylene oxidation and significantly slows epoxidation of electron-deficient olefins (k<sub>C</sub><sub>-H[O]</sub>/k<sub>epox</sub> = 38.5). Chemoselective methylene oxidation is demonstrated in forty-five molecules housing α,β-unsaturated carbonyl functionality, where all previous methods afforded allylic oxidation or epoxidation. Mechanistic studies support that the new oxidant operates via a more charged pathway that disfavours electron-deficient bonds, demonstrating that highly reactive metal oxidants can be tuned to achieve chemoselectivity. These findings enable the first late-stage oxidations in complex natural products and derivatives containing these pharmacophoric substructures, providing access to both new analogues and known metabolites.
Medical subject headings
- Biological Products
- Alkenes
- Methane